Previous close | 2.0500 |
Open | 2.0500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 120.00 |
Expiry date | 2025-01-17 |
Day's range | 2.0500 - 2.0500 |
Contract range | N/A |
Volume | |
Open interest | 161 |
West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Edwards Lifesciences fair value estimate is US$76.62 With...